Pure Global
NCT06270979

Intrinsic Capacity and Functional Ability Monitoring With an Integrated Data Eco-System for Healthy Ageing.

Feasibility and Usability of Intrinsic Capacity Monitoring With an Integrated Data Eco-System for Healthy Ageing, and Its Association With Health Outcomes in Older Patients Undergoing Rehabilitation and in Older Nursing Home Residents.
Prof. Ivan Bautmans·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Frailty
Drug/Device/Intervention
ISHA
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Prof. Ivan Bautmans
Funder
Vrije Universiteit Brussel
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Apr 01, 2025
Enrollment
120 participants
Primary outcome

Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Potential technical problems of the ISHA system,Experiences with ISHA (usability, feasibility and acceptability outcome)

Summary

In this study, 120 older adults (aged 65 years or older) either patients undergoing
 rehabilitation or older nursing home residents will be provided with an Eforto® device and
 the eco-System for Healthy Ageing (ISHA) mobile application to self-monitor intrinsic
 capacity for 4 months (if needed with assistance by an (in)formal caregiver). Preferably, the
 participants will use their own smartphone because mitigating smartphone-use-related issues.
 
 The aims of the study are:
 
 1. to evaluate the usability and feasibility of self-monitoring intrinsic capacity by using
 the ISHA system in rehabilitation and nursing home settings.
 
 2. to investigate if changes and variability in intrinsic capacity as measured with ISHA
 are related to changes in functional ability and quality of life.
 
 3. to explore individual trajectories of intrinsic capacity with the ISHA system.

ICD-10 classifications
Unattended deathIndividuals with autosomal fragile site
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06270979
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06270979 through Pure Global AI's free database. This phase not specified trial is sponsored by Prof. Ivan Bautmans and is currently Not yet recruiting. The study focuses on Frailty. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.